Antiangiogenesis for cancer therapy
- 1 May 1997
- journal article
- review article
- Published by Elsevier in The Lancet
- Vol. 349, S13-S15
- https://doi.org/10.1016/s0140-6736(97)90014-3
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisPublished by Elsevier ,1996
- Cell adhesion molecules in angiogenesisCancer and Metastasis Reviews, 1996
- Regulation of VEGF/VPF expression in tumor cells: Consequences for tumor growth and metastasisCancer and Metastasis Reviews, 1996
- In situ detection of tissue factor in vascular endothelial cells: Correlation with the malignant phenotype of human breast diseaseNature Medicine, 1996
- Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumoursNature, 1996
- Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppressionNature Medicine, 1995
- Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinomaCell, 1994
- Tumor Angiogenesis: A New Significant and Independent Prognostic Indicator in Early-Stage Breast CarcinomaJNCI Journal of the National Cancer Institute, 1992
- Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancerThe Lancet, 1992
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI Journal of the National Cancer Institute, 1990